Zobrazeno 1 - 10
of 134
pro vyhledávání: '"Menapace LA"'
Autor:
Pipe SW M.D; University of Michigan, Ann Arbor, Michigan, United States., Lissitchkov TJ; SBALHZ EAD, Sofia, Bulgaria., Georgiev P; University Multiprofile Hospital for Active Treatment 'Sveti Georgi', Plovdiv, Clinic of Hematology and Medical University Plovdiv, Plovdiv,, Bulgaria., Mangles S; Hampshire Hospitals NHS Foundation Trust, Basingstoke, United Kingdom., Hegemann I; University Hospital Zurich, Zurich, Switzerland., Trinchero A; University Hospital Zurich, Zurich, Switzerland., Chowdary P; Royal Free Hospital, London, United Kingdom., Forbes A; Royal Cornwall Hospital, Cornwall, United Kingdom., Feng L; Sanofi, Shanghai, China., Menapace LA; Sanofi, Cambridge, Massachusetts, United States., Kichou S; Sanofi, Paris, France., Andersson SR; Sanofi, Cambridge, MA, Cambridge, Massachusetts, United States., Demissie M; Sanofi, Cambridge, Massachusetts, United States., Ragni MV; University of Pittsburgh, Pittsburgh, Pennsylvania, United States.
Publikováno v:
Blood advances [Blood Adv] 2024 Dec 06. Date of Electronic Publication: 2024 Dec 06.
Autor:
Xu JZ; Sickle Cell Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Conrey A; Sickle Cell Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Frey I; Sickle Cell Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Gwaabe E; Sickle Cell Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Menapace LA; Sickle Cell Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Tumburu L; Sickle Cell Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Lundt M; Sickle Cell Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Lequang T; Sickle Cell Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Li Q; Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD., Glass K; Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD., Dunkelberger EB; Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD., Iyer V; Agios Pharmaceuticals, Inc., Cambridge, MA., Mangus H; Agios Pharmaceuticals, Inc., Cambridge, MA., Kung C; Agios Pharmaceuticals, Inc., Cambridge, MA., Dang L; Agios Pharmaceuticals, Inc., Cambridge, MA., Kosinski PA; Agios Pharmaceuticals, Inc., Cambridge, MA., Hawkins P; Agios Pharmaceuticals, Inc., Cambridge, MA., Jeffries N; Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Eaton WA; Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD., Lay Thein S; Sickle Cell Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
Publikováno v:
Blood [Blood] 2022 Nov 10; Vol. 140 (19), pp. 2053-2062.
Autor:
Lorenzini, Jacopo (AUTHOR) jacopo.lorenzini2@unibo.it
Publikováno v:
Quellen und Forschungen aus Italienischen Archiven und Bibliotheken. Nov2024, Vol. 104 Issue 1, p469-500. 32p.
Autor:
Menapace LA; Sickle Cell Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Thein SL; Sickle Cell Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA. sl.thein@nih.gov.
Publikováno v:
Haematologica [Haematologica] 2020 Nov 01; Vol. 105 (11), pp. 2501-2504. Date of Electronic Publication: 2020 Nov 01.
Autor:
Roydhouse JK; ORISE Fellow, Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, Food and Drug Administration (US FDA), Silver Spring, MD, USA; Menzies Institute for Medical Research, University of Tasmania, Hobart TAS, Australia. Electronic address: jessica.roydhouse@utas.edu.au., Menapace LA; Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, US FDA, Silver Spring, MD, USA; National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD, USA., Xia H; Division of Clinical Pharmacology, Center for Drug Evaluation and Research, US FDA, Silver Spring, MD, USA., Song P; Division of Clinical Pharmacology, Center for Drug Evaluation and Research, US FDA, Silver Spring, MD, USA., Berman T; Office of Oncologic Diseases, Center for Drug Evaluation and Research, US FDA, Silver Spring, MD, USA., Agarwal R; New Drug Products Branch II, Center for Drug Evaluation and Research, US FDA, Silver Spring, MD, USA., Suzman DL; Office of Oncologic Diseases, Center for Drug Evaluation and Research, US FDA, Silver Spring, MD, USA., Wright K; Office of Prescription Drug Promotion, Center for Drug Evaluation and Research, US FDA, Silver Spring, MD, USA., Beaver JA; Office of Oncologic Diseases, Center for Drug Evaluation and Research, US FDA, Silver Spring, MD, USA., Kluetz PG; Oncology Center of Excellence, US FDA, Silver Spring, MD, USA.
Publikováno v:
Complementary therapies in medicine [Complement Ther Med] 2020 Nov; Vol. 54, pp. 102549. Date of Electronic Publication: 2020 Aug 29.
Autor:
Boggan, Michaela1,2,3, Edwards, Christopher L.1,2,3 cedwards@nccu.edu, Meek, Jordan1,2,3, Wood, Mary4, Bryson, W. Jeff5, Sollers, John J.1,2,3, Parker, Debra O.1,2,3, Barker, Camela S.2,5, Miller, Jessica2,6, Downey, Brianna2,5, Lockett, Asha2,5, Rosales, Jazmin1,2,3, Munroe Jr., Courtney2, Wax, Noa2,5, Scott, Sharena1,2,3, Pittman, Bridget1,2,3, Turner, Merell1,2,3, Dietahin, Hillary T.1,2,3, Smith, Eric1,2,3, McDougald, Alexandria1,2,3
Publikováno v:
Italian Journal of Medicine. 2024, Vol. 18 Issue 3, p1-7. 7p.
Autor:
Roydhouse JK; Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland., Suzman DL; Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland., Menapace LA; Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland., Mishra-Kalyani PS; Office of Biostatistics, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland., Sridhara R; Office of Biostatistics, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland., Blumenthal GM; Oncology Center of Excellence, Food and Drug Administration, Silver Spring, Maryland., Beaver JA; Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland., Pazdur R; Oncology Center of Excellence, Food and Drug Administration, Silver Spring, Maryland., Kluetz PG; Oncology Center of Excellence, Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
JAMA oncology [JAMA Oncol] 2019 Nov 01; Vol. 5 (11), pp. e192971. Date of Electronic Publication: 2019 Nov 14.
Autor:
Menapace LA; Taussig Cancer Institute, Department of Hematology Oncology, Cleveland Clinic, Cleveland, Ohio, USA., McCrae KR; Taussig Cancer Institute, Department of Hematology Oncology, Cleveland Clinic, Cleveland, Ohio, USA., Khorana AA; Taussig Cancer Institute, Department of Hematology Oncology, Cleveland Clinic, Cleveland, Ohio, USA. Electronic address: Khorana@ccf.org.
Publikováno v:
Thrombosis research [Thromb Res] 2016 Apr; Vol. 140 Suppl 1, pp. S93-8.
Publikováno v:
Current Opinion in Hematology; 2010 Sep, Vol. 17 Issue 5, p450-456, 7p
Autor:
Laurence, Jeffrey
Publikováno v:
Clinical Advances in Hematology & Oncology; Oct2024, Vol. 22 Issue 8, p381-391, 11p